Navigation Links
PRN Physician Recommended Nutriceuticals Selected for the Second Consecutive Year to the Inc. 500|5000 List of Fastest-Growing Privately Held Companies
Date:8/21/2013

PLYMOUTH MEETING, Pa., Aug. 21, 2013 /PRNewswire/ -- PRN Physician Recommended Nutriceuticals, a premiere provider of high-quality omega-3 and nutritional supplements, today announced their selection for the second consecutive year to the Inc. 500|5000 list, an exclusive ranking of the nation's fastest-growing privately held companies. With three-year revenue growth of 265%, PRN additionally ranked an impressive sixth among healthcare companies in Pennsylvania. 

Kenneth Krieg, CEO of PRN Physician Recommended Nutriceuticals, noted, "We are very pleased to have achieved this milestone two years in a row.  In this economy, it is very challenging to realize significant growth, but PRN's unique business model and unparalleled product quality have been fundamental in driving our success over the past five years.  This achievement was further supported by the fact that clinical research continues to validate our unique product formulations, as evidenced by the recent data release from the AREDS2 study on macular degeneration."

For companies honored on the 2013 list, the median sales increase was greater than 140 percent, the highest median increase in Inc. 500/5000 history.  PRN now shares a pedigree with other multi-year awardees including Intuit, Zappos, Under Armour, Pandora, Microsoft, Timberland, and Oracle.

About PRN Physician Recommended Nutriceuticals

PRN is a leading developer of specialty omega-3 products and nutritional supplements. Developed by doctors and recommended by world-renowned medical thought leaders, PRN products are supported by vast bodies of clinical evidence. Additionally, PRN product formulations and manufacturing practices are designed to ensure purity and to maximize the body's absorption of the key ingredients like omega-3 (EPA/DHA), uniquely enabling patients to receive the optimal dose of these essential nutrients.

About Inc.

Founded in 1979 and acquired in 2005 by Mansueto Ventures, Inc. is the only major brand dedicated exclusively to owners and managers of growing private companies, with the aim to deliver real solutions for today's innovative company builders.  Total monthly audience reach for the brand has grown significantly from 2,000,000 in 2010 to over 6,000,000 today.  For more information, visit www.inc.com.


'/>"/>
SOURCE PRN Physician Recommended Nutriceuticals
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Senator Shares Insight on Florida Physician Dispensing Legislation as First Guest of Progressive Medicals New SignatureSeries
2. Physicians Practice Wins Multiple Awards for Digital and Print Excellence
3. Orange County Physician Owned Medical Group Opens Pioneering Medical Facility
4. Physicians Expect More Out of Tablet-Toting Pharmaceutical Sales Reps, Study Finds
5. Recent Study Reveals Physicians Prefer Topical Delivery for Drug Delivery Technology, Such as a Transdermal Patch
6. Parents May Have Even More Reason to Explore Weight Loss Surgery, suggests Beverly Hills Physicians
7. After Reviewing Brief Product Profiles, Surveyed Physicians Believe that Likely Candidates for Late-Phase Chronic Kidney Disease Products from AbbVie, Mitsubishi Tanabe, Eli Lilly, Concert, Fibrogen and Pfizer are Typically Stage 3b and 4 Patients
8. Patients and Physicians Express Desire to Switch to Transdermal Drug Delivery, Finds Frost & Sullivan
9. Emergency Physicians Use New Tool to Detect Drug-Seekers in the ER
10. New Medication Management And Adherence App, MyMeds, Introduced For iPhone, Android, Web; Unites Consumers, Pharmacists, Caregivers, Physicians
11. Frost & Sullivan: Physicians Focus on RCM Solutions to Prepare for New Wave of Financial Challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb. 23, 2017  Cogentix Medical, Inc. ... and markets innovative proprietary products for the urology market, ... fiscal year ended December 31, 2016 before the market ... The Company will host a conference call and webcast ... Thursday, March 9, 2017 at 11:00 a.m. Eastern Time ...
(Date:2/23/2017)... Feb 23, 2017 Research and Markets has announced ... 2016" report to their offering. ... The latest research Menopause Drugs Price Analysis and Strategies - ... The research answers the following questions: ... How are they positioned in the Global Menopause market? ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... - 2016" report to their offering. ... The latest research Fibromyalgia Drugs Price ... in the global Fibromyalgia market. The research answers the ... marketed for Fibromyalgia and their clinical attributes? How are they positioned ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... ... , media relations, content marketing, social media management, corporate communications, SEO and cause ... the state and in nearby New Hampshire, Massachusetts and Canada, Rosica will focus ...
(Date:2/23/2017)... Colorado (PRWEB) , ... February 23, 2017 , ... ... Magazine, an exciting, new, interactive publication where generations converge and explore the world ... expand their worldview, Dialog Magazine enables readers to gain understanding, increase empathy, and ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... new partnership with the Rhode Island Consortium for Autism Research and Treatment (RI-CART) ... for children with autism spectrum disorder (ASD) to see films in an environment ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/22/2017)... York (PRWEB) , ... February 22, 2017 , ... ... entrance and lobby of a new healthcare contact center in Georgia, PENETRON Specialty ... One of the nation’s largest healthcare systems recently invested $51 million to purchase ...
Breaking Medicine News(10 mins):